Volume 8, Issue 3 (11-1994)                   Med J Islam Repub Iran 1994 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
KALANTAR MOTAMEDI M, KALANTAR MOTAMEDI M. CAROTID BODY TUMORS OUR EXPERIENCE WITH 20 PATIENTS. Med J Islam Repub Iran 1994; 8 (3) :141-147
URL: http://mjiri.iums.ac.ir/article-1-1371-en.html
CAROTID BODY TUMORS OUR EXPERIENCE WITH 20 PATIENTS
MOHAMMADREZA KALANTAR MOTAMEDI , MOHAMMADHASAN KALANTAR MOTAMEDI
From the Department of General and Vascular Surgery, Shohada Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, I.R. Iran.
Abstract:   (4625 Views)
In this report of 20 patients with 24 carotid body tumors which is the largest series reported so far from Iran, we have evaluated the various characteristics of this relatively rare tumor in our population and compared our results with that of the literature. Although the prevalence of the tumor is cited to be equal among both sexes, we found a female to male ratio of 2.3 to I, as 14 of our patients were female and 6 were male. The tumor was as equally frequent on the right as it was on the left, and was bilateral in four cases. The average tumor size was 5.3 cm in diameter and was found to be malignant in four cases. The results we obtained following the careful surgical technique which is described in detail compares quite favorably with that in the literature: 3 cases of cranial nerve injury (12.5%) compared to an average of 45% nerve injury in the reports, and no perioperative death versus 2% perioperative mortality in the literature. Also we had no instances of stroke, transient ischemia, Horner's syndrome, or other complications. We propose the surgical technique detailed by the author as the method of choice for treatment of carotid body tumors in Iranian patients.
Full-Text [PDF 679 kb]   (2302 Downloads)    
Type of Study: Original Research | Subject: Surgery
Add your comments about this article : Your username or Email:
CAPTCHA
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.